PTGES3 is a Putative Prognostic Marker in Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Surgery
Reference33 articles.
1. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor;Harris;Cancer Res,2000
2. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators;Schrey;Br. J. Cancer,1995
3. Cyclooxygenase-2: A potential target in breast cancer;Wang;Semin. Oncol.,2004
4. Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer;Pockaj;Ann. Surg. Oncol.,2004
5. Prostaglandin E 2 enhances intestinal adenoma growth via activation of the ras-mitogen-activated protein kinase cascade;Wang;Cancer Res,2005
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Icariside II Suppresses the Malignant Behaviors of Breast Cancer Cells by Inhibiting PTGES3 Expression;Revista Brasileira de Farmacognosia;2024-08-30
2. RBM14 enhances transcriptional activity of p23 regulating CXCL1 expression to induce EMT in lung cancer;2024-02-09
3. Screening of Lipid Metabolism-Related Genes as Diagnostic Indicators in Chronic Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2023-11
4. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma;Analytical Cellular Pathology;2023-06-28
5. Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma;Frontiers in Oncology;2023-05-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3